Zoom’s healthcare presence rose during the pandemic and it has since invested or partnered with companies including Epic and Oracle. Credit: Primakov / Shutterstock.com

Zoom’s VC arm has invested in Medaica to advance the latest version of the latter’s telehealth platform.

Medaica’s ‘Telehealth 2.0’ platform is under development to give clinicians the ability to examine, detect, diagnose, and monitor patients remotely and in real time.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

With the communication company’s investment, the value of which has not been disclosed, Medaica is building an ecosystem of medical devices, AI and diagnostic tools that can bring clinical examinations to “every home and care facility”, according to the company’s CEO, Stephen Randall.

This development aims to build on Medaica’s existing remote examination technology, known as the Medaica M1 telehealth stethoscope platform, which secured US Food and Drug Administration (FDA) clearance in February 2025. Under this aim, Medaica says it plans to connect medical devices, clinicians, and artificial intelligence (AI)-based tools to expand access to virtual care.

Zoom’s chief strategy officer, Abhisht Arora, commented: “Zoom’s investment in Medaica is an extension of our longstanding commitment to connecting clinicians, patients, and staff, regardless of location, and equipping them with tools that enhance care and reduce the administrative burden. Medaica enhances care from anywhere, establishing digital-first clinical examinations as a new standard for accessible, high-value, and on-demand healthcare delivery.”

The latest investment for Zoom is far from its first foray into healthcare. Since the pandemic, the company has expanded its presence in the telehealth and telemedicine space. Aside from Zoom’s own product offerings, including AI healthcare dictation service Zoom Clinical Notes, it has also established integrations with electronic healthcare record (EHR) companies in the US, including Epic, Oracle Cerner Millennium, and Athenahealth.

GlobalData analysis reveals that the global telehealth market is growing at a compound annual growth rate (CAGR) of 5.95% and is projected to reach a valuation of around $716m in 2035, up from $403m in 2025.